icad inc. (ICAD): Price and Financial Metrics
ICAD Price/Volume Stats
| Current price | $1.55 | 52-week high | $3.97 |
| Prev. close | $1.59 | 52-week low | $1.05 |
| Day low | $1.54 | Volume | 47,999 |
| Day high | $1.62 | Avg. volume | 194,582 |
| 50-day MA | $1.63 | Dividend yield | N/A |
| 200-day MA | $1.84 | Market Cap | 41.14M |
ICAD Stock Price Chart Interactive Chart >
icad inc. (ICAD) Company Bio
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company was founded in 1984 and is based in Nashua, New Hampshire.
Latest ICAD News From Around the Web
Below are the latest news stories about ICAD INC that investors may wish to consider to help them evaluate ICAD as an investment opportunity.
iCAD Expands Executive Sales Leadership Team as Business GrowsBill Keyes shifts and expands his role to Senior Vice President, Global Sales Operations and Peter Graham joins iCAD as Senior Vice President, North American Sales to accelerate growth while organization adds new products and partnerships.NASHUA, N.H., Dec. 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice Presi |
Wealth Accumulation: 3 Stocks with Multibagger PotentialWhile it’s never easy to identify multibagger stocks, this may be one of the best times in decades to “swing for the fences” by buying undervalued growth names that are well-positioned to at least triple over the next few years. Amid excessive worries about interest rates, the Street has pushed down many unprofitable, high-potential companies’ stocks to absurdly low levels. Now that those fears are dissipating, these firms are well-positioned to make huge comebacks. Interest rates recently dropp |
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE HealthcareKey apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast care, including cancer detection, density assessment, and recommendations NASHUA, N.H., Nov. 28, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions |
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart DiseaseNew research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast canceriCAD unveils new solution that assesses calcium deposits in the breast arteries as a proxy for hidden cardiovascular disease, the leading cause of death for women in the U.S.Dr. Emily Conant, Perelman School of Medicine, University of Pennsylvania, to present how iCAD’s 4th generation Breast AI is harnessing inn |
Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive ReturnsAs the Street realizes that we're in the early stages of the business cycle, penny stocks should boom. |
ICAD Price Returns
| 1-mo | 0.00% |
| 3-mo | 0.65% |
| 6-mo | -3.13% |
| 1-year | 6.90% |
| 3-year | -90.88% |
| 5-year | -66.08% |
| YTD | -12.43% |
| 2023 | -3.28% |
| 2022 | -74.58% |
| 2021 | -45.45% |
| 2020 | 69.88% |
| 2019 | 110.00% |
Continue Researching ICAD
Want to do more research on Icad Inc's stock and its price? Try the links below:Icad Inc (ICAD) Stock Price | Nasdaq
Icad Inc (ICAD) Stock Quote, History and News - Yahoo Finance
Icad Inc (ICAD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...